2 results
Approved WMOCompleted
The objective of this study is to observe the anatomical and functional outcomes of ocriplasmin over a 6-month follow-up period.
Approved WMOCompleted
To evaluate the efficacy and safety of T-817MA in patients with mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease.